Cargando…
Alpelisib-Induced Diabetes Mellitus: Case Report, Pharmacodynamics and Management Considerations
INTRODUCTION: Alpelisib is an orally selective PI3K alpha inhibitor recently available for the treatment of advanced breast cancer. PI3K pathway is an intracellular signaling pathway that plays an important role in regulating glucose metabolism. Hyperglycemia is the most common adverse event associa...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843667/ https://www.ncbi.nlm.nih.gov/pubmed/35178031 http://dx.doi.org/10.3389/fendo.2022.802612 |